Boditech Media - Boditech Med

PRESS RELEASE

Boditech Med, Obtains Export Permit for the Biomarker 'PenKid' for Acute Kidney Injury Diagnosis

Obtained an Export Permit for PenKid, which enables a rapid diagnosis of acute kidney injury within 15 minutes

PRESS RELEASE

Boditech Med and Joinstar, Agreement for Chronic Disease Diagnosis in China

Joinstar will be supplied with key components of cartridges used in chronic disease diagnosis.

PRESS RELEASE

Boditech Med has obtained the export license of COVID-19 Ag Saliva rapid test kit

With a simple and safe sample collection, it can detect COVID-19 antigen in 15 minutes

PRESS RELEASE Boditech Med Showcases Next-Gen Diagnostic Solutions at ADLM 2025, Expanding Presence in Americas
Highlights include AFIAS automated immunoassay platform and key products like IGRA-TB and PENKID
PRESS RELEASE Boditech Med and HLB LifeCare Sign MOU to Develop AI-Based Chronic Disease Diagnostics
Aimed at early detection and improved accessibility through personalized diagnostics
PRESS RELEASE Boditech Med’s Dengue Diagnostic Kits Selected by WHO Expert Review Panel for Diagnostics (ERPD)
Selected by WHO ERPD to support global dengue response efforts
PRESS RELEASE Boditech Med Reports Strong Q1 2025 Performance with Double-Digit Growth
Q1 2025 consolidated revenue reaches $28.7 million (₩39.1 billion), operating profit $5.9 million (₩8.1 billion)
PRESS RELEASE Boditech Med Unveils Next-Generation Infectious Disease Diagnostic Platforms at ESCMID Global 2025
Showcased point-of-care solutions for latent tuberculosis and infection differentiation using the AFIAS platform
PRESS RELEASE Boditech Med Receives ANVISA Approval for Four Diagnostic Kits for Dengue Fever and Latent TB
Products classified as Class III high-risk medical devices; approved following local clinical performance evaluations
PRESS RELEASE Boditech Med Holds Completion Ceremony for New Manufacturing Plant in India
New factory established in Jhajjar, India to enhance price competitiveness through local production
PRESS RELEASE Boditech Med Showcases Innovative IVD Solutions at CACLP 2025 in China
Cardiovascular and acute chest pain diagnostic panel, featuring ST2 & NT-proBNP, draws significant attention
PRESS RELEASE Boditech Med Receives Approval for Seven AFIAS Diagnostic Kits from Russia’s Health Authority
Certification completed for seven AFIAS kits: four for cardiovascular diseases and three for inflammatory markers
PRESS RELEASE Boditech Med Reports 2024 Revenue of $103.8 Million (138.1 Billion KRW), Up 2.9% Year-on-Year
Strong sales growth maintained across key regions, including Europe, Asia, the Middle East, and Africa.

1 2 3 4 5

Smart Guide